Peptilogics

Developer of a therapeutic and drug discovery peptide platform designed to treat multidrug-resistant bacterial infections. The company's platform offers a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) that has preclinical effectiveness against resistant bacteria and biofilms, enabling doctors to identify and treat bacterial infections at an affordable cost.

Founders Fund

🏥 Healthcare